Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.

Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA.

Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. doi: 10.1186/s12969-019-0309-6.

2.

Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.

Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G.

J Pediatr. 2013 Jun;162(6):1245-51. doi: 10.1016/j.jpeds.2012.11.081. Epub 2013 Jan 17.

PMID:
23333131
3.

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.

Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao YJ, Anton J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ, Ravelli A, Horne A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

J Pediatr. 2017 Oct;189:72-78.e3. doi: 10.1016/j.jpeds.2017.06.005. Epub 2017 Aug 12.

PMID:
28807357
4.

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite NT, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

Arthritis Rheumatol. 2014 Oct;66(10):2871-80. doi: 10.1002/art.38769.

5.

Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

Demirkol D, Yildizdas D, Bayrakci B, Karapinar B, Kendirli T, Koroglu TF, Dursun O, Erkek N, Gedik H, Citak A, Kesici S, Karabocuoglu M, Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study Group.

Crit Care. 2012 Dec 12;16(2):R52. doi: 10.1186/cc11256.

6.

Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.

Lin M, Park S, Hayden A, Giustini D, Trinkaus M, Pudek M, Mattman A, Schneider M, Chen LYC.

Ann Hematol. 2017 Aug;96(8):1241-1251. doi: 10.1007/s00277-017-2993-y. Epub 2017 May 12. Review.

PMID:
28497365
7.

Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.

Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P.

Rheumatology (Oxford). 2015 Aug;54(8):1507-17. doi: 10.1093/rheumatology/keu524. Epub 2015 Mar 12.

PMID:
25767156
8.

Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.

Gupta AA, Tyrrell P, Valani R, Benseler S, Abdelhaleem M, Weitzman S.

J Pediatr Hematol Oncol. 2009 Feb;31(2):81-4. doi: 10.1097/MPH.0b013e3181923cb4.

PMID:
19194188
9.

The rheumatology/hematology interface: CAPS and MAS diagnosis and management.

Gansner JM, Berliner N.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):313-317. doi: 10.1182/asheducation-2018.1.313. Review.

PMID:
30504326
10.

A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.

Kumar B, Aleem S, Saleh H, Petts J, Ballas ZK.

J Clin Immunol. 2017 Oct;37(7):638-643. doi: 10.1007/s10875-017-0439-x. Epub 2017 Sep 4.

PMID:
28871523
11.

Similar but not the same: Differential diagnosis of HLH and sepsis.

Machowicz R, Janka G, Wiktor-Jedrzejczak W.

Crit Rev Oncol Hematol. 2017 Jun;114:1-12. doi: 10.1016/j.critrevonc.2017.03.023. Epub 2017 Mar 23. Review.

PMID:
28477737
12.

Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.

Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A.

Clin Exp Immunol. 2018 Mar;191(3):349-355. doi: 10.1111/cei.13026. Epub 2017 Sep 15.

14.

Hemophagocytic lymphohistiocytosis: when the immune system runs amok.

Janka G.

Klin Padiatr. 2009 Sep;221(5):278-85. doi: 10.1055/s-0029-1237386. Epub 2009 Aug 25. Review.

PMID:
19707989
15.

Histiocytic disorders: recent insights into pathophysiology and practical guidelines.

Filipovich A, McClain K, Grom A.

Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S82-9. doi: 10.1016/j.bbmt.2009.11.014. Epub 2009 Nov 22. Review.

16.
17.

Macrophage activation syndrome and cytokine-directed therapies.

Schulert GS, Grom AA.

Best Pract Res Clin Rheumatol. 2014 Apr;28(2):277-92. doi: 10.1016/j.berh.2014.03.002. Review.

18.

[Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Lachmann G, La Rosée P, Schenk T, Brunkhorst FM, Spies C.

Anaesthesist. 2016 Oct;65(10):776-786. Review. German.

PMID:
27612865
19.

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G.

Pediatr Blood Cancer. 2007 Feb;48(2):124-31.

PMID:
16937360
20.

Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.

Hayden A, Park S, Giustini D, Lee AY, Chen LY.

Blood Rev. 2016 Nov;30(6):411-420. doi: 10.1016/j.blre.2016.05.001. Epub 2016 May 20. Review.

Supplemental Content

Support Center